Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | breast cancer 1, early onset | Starlite/ChEMBL | No references |
Homo sapiens | SMAD family member 2 | Starlite/ChEMBL | No references |
Homo sapiens | nuclear factor, erythroid 2-like 2 | Starlite/ChEMBL | No references |
Homo sapiens | GNAS complex locus | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | MH2 domain containing protein | SMAD family member 2 | 467 aa | 405 aa | 31.6 % |
Schistosoma mansoni | GTP-binding protein alpha subunit gna | GNAS complex locus | 394 aa | 450 aa | 28.7 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | 0.0012 | 0.0465 | 0.0465 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.274 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.274 | 1 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0012 | 0.0465 | 0.5 |
Brugia malayi | hypothetical protein | 0.0012 | 0.0465 | 0.0465 |
Brugia malayi | Pax transcription activation domain interacting protein | 0.0012 | 0.0465 | 0.0465 |
Brugia malayi | MH2 domain containing protein | 0.001 | 0.0316 | 0.0316 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0055 | 0.359 | 1 |
Wolbachia endosymbiont of Brugia malayi | NAD-dependent DNA ligase, Lig | 0.0012 | 0.0465 | 0.5 |
Brugia malayi | hypothetical protein | 0.0012 | 0.0465 | 0.0465 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0043 | 0.274 | 0.7404 |
Schistosoma mansoni | chromosome transmission fidelity factor | 0.0012 | 0.0465 | 0.0455 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0144 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0012 | 0.0465 | 0.5 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.359 | 1 |
Mycobacterium ulcerans | NAD-dependent DNA ligase LigA | 0.0012 | 0.0465 | 0.5 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0055 | 0.359 | 0.359 |
Loa Loa (eye worm) | hypothetical protein | 0.0012 | 0.0465 | 0.0465 |
Trichomonas vaginalis | chromosome transmission fidelity factor, putative | 0.0012 | 0.0465 | 0.5 |
Brugia malayi | ATP dependent DNA ligase C terminal region family protein | 0.0012 | 0.0465 | 0.0465 |
Brugia malayi | MH1 domain containing protein | 0.001 | 0.0316 | 0.0316 |
Loa Loa (eye worm) | MH1 domain-containing protein | 0.001 | 0.0316 | 0.0316 |
Brugia malayi | MH2 domain containing protein | 0.001 | 0.0316 | 0.0316 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0055 | 0.359 | 1 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.359 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0012 | 0.0465 | 0.0465 |
Schistosoma mansoni | topbp1 | 0.0012 | 0.0465 | 0.0455 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.001 | 0.0316 | 0.0316 |
Echinococcus granulosus | nibrin | 0.0012 | 0.0465 | 0.0455 |
Schistosoma mansoni | hypothetical protein | 0.0043 | 0.274 | 0.7404 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.274 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0012 | 0.0465 | 0.5 |
Trichomonas vaginalis | RNA polymerase II ctd phosphatase, putative | 0.0012 | 0.0465 | 0.5 |
Trypanosoma cruzi | FHA domain containing protein, putative | 0.0012 | 0.0465 | 0.5 |
Echinococcus multilocularis | replication factor c subunit 1 | 0.0012 | 0.0465 | 0.0455 |
Schistosoma mansoni | DNA ligase IV | 0.0012 | 0.0465 | 0.0455 |
Brugia malayi | topoisomerase | 0.0012 | 0.0465 | 0.0465 |
Plasmodium vivax | replication factor C subunit 1, putative | 0.0012 | 0.0465 | 0.5 |
Giardia lamblia | Replication factor C, subunit 1 | 0.0012 | 0.0465 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0012 | 0.0465 | 0.0465 |
Trichomonas vaginalis | replication factor C large subunit, putative | 0.0012 | 0.0465 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.274 | 1 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.359 | 1 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0043 | 0.274 | 0.7404 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0012 | 0.0465 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0012 | 0.0465 | 0.5 |
Toxoplasma gondii | ATPase, AAA family protein | 0.0012 | 0.0465 | 0.5 |
Schistosoma mansoni | topbp1 | 0.0012 | 0.0465 | 0.0455 |
Brugia malayi | MH1 domain containing protein | 0.001 | 0.0316 | 0.0316 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0012 | 0.0465 | 0.5 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0055 | 0.359 | 1 |
Echinococcus multilocularis | nibrin | 0.0012 | 0.0465 | 0.0455 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0055 | 0.359 | 0.359 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0055 | 0.359 | 1 |
Brugia malayi | DKFZp564C0469 protein | 0.0012 | 0.0465 | 0.0465 |
Chlamydia trachomatis | DNA ligase | 0.0012 | 0.0465 | 0.5 |
Treponema pallidum | DNA ligase (lig) | 0.0012 | 0.0465 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0012 | 0.0465 | 0.0465 |
Mycobacterium leprae | PROBABLE DNA LIGASE [NAD DEPENDENT] LIGA (POLYDEOXYRIBONUCLEOTIDE SYNTHASE [NAD+]) | 0.0012 | 0.0465 | 0.5 |
Loa Loa (eye worm) | Smad1 | 0.001 | 0.0316 | 0.0316 |
Brugia malayi | Smad1 | 0.001 | 0.0316 | 0.0316 |
Trypanosoma brucei | BRCA1 C Terminus (BRCT) domain containing protein, putative | 0.0012 | 0.0465 | 0.5 |
Plasmodium falciparum | replication factor C subunit 1, putative | 0.0012 | 0.0465 | 0.5 |
Brugia malayi | hypothetical protein | 0.0043 | 0.274 | 0.274 |
Echinococcus granulosus | replication factor c subunit 1 | 0.0012 | 0.0465 | 0.0455 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0012 | 0.0465 | 0.5 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0144 | 1 | 1 |
Trichomonas vaginalis | RNA polymerase II ctd phosphatase, putative | 0.0012 | 0.0465 | 0.5 |
Trypanosoma cruzi | BRCA1 C Terminus (BRCT) domain containing protein, putative | 0.0012 | 0.0465 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0012 | 0.0465 | 0.0465 |
Toxoplasma gondii | poly(ADP-ribose) polymerase catalytic domain-containing protein | 0.0012 | 0.0465 | 0.5 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0043 | 0.274 | 0.7404 |
Trichomonas vaginalis | chromosome transmission fidelity factor, putative | 0.0012 | 0.0465 | 0.5 |
Onchocerca volvulus | 0.0012 | 0.0465 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 3.2643 uM | PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648] | ChEMBL. | No reference |
Potency (functional) | 3.5481 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] | ChEMBL. | No reference |
Potency (functional) | 3.9811 uM | PubChem BioAssay. qHTS Assay to Identify Small Molecule Activators of BRCA1 Expression. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 7.0795 uM | PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 79.4328 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.